Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis

NCT01066104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis
Nasal Polyps

Interventions

DRUG: Xolair placebo
DRUG: Xolair (omalizumab)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]